Á lódáil...
Future prospects for contact factors as therapeutic targets
Anticoagulants currently used in clinical practice to treat or prevent thromboembolic disease are effective, but place patients at increased risk for serious bleeding because they interfere with plasma enzymes (thrombin and factor Xa) that are essential for hemostasis. In the past 10 years, work wit...
Na minha lista:
| Foilsithe in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2014
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4364029/ https://ncbi.nlm.nih.gov/pubmed/25696834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/asheducation-2014.1.52 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|